Yoon, Hyunho
Tang, Chih-Min
Banerjee, Sudeep
Delgado, Antonio L.
Yebra, Mayra
Davis, Jacob
Sicklick, Jason K. http://orcid.org/0000-0003-4403-0271
Article History
Received: 11 September 2020
Revised: 17 December 2020
Accepted: 13 January 2021
First Online: 6 February 2021
Conflict of interest
: J.K.S. receives research funding from Novartis Pharmaceuticals, Amgen Pharmaceuticals, and Foundation Medicine, consultant fees from Grand Rounds, Loxo, and Deciphera, speaker’s fees from Roche and Deciphera, and owns stocks in Personalis.